Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?
- 31 August 2020
- journal article
- review article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 58 (9)
- https://doi.org/10.1128/JCM.01950-19
Abstract
QuantiFERON-TB Gold Plus (QFT-Plus) is the latest generation of interferon gamma release assays (IGRAs) to receive approval from the US. FDA, replacing its predecessor, QuantiFERON-TB Gold In-Tube (QFT-GIT). The novelty of OFT-Plus is that it elicits a response from CD8 T cells, in addition to CD4 T cells, thus collecting a broader response from T-cell subsets than QFT-GIT. It was developed with the aim to improve the detection of latent tuberculosis infection (LTBI), especially among recently exposed contacts, immunocompromised hosts, and young children. In this minireview, we summarize the performance of QFT-Plus compared with that of QFT-GIT among active tuberculosis (TB) patients (a surrogate for LTBI patients), high-risk populations, and low-risk individuals based on recent publications. Studies comparing QFT-Plus to QFT-GIT currently do not support the superior performance of QFT-Plus in individuals with active TB and LTBI. The difference in sensitivity between QFT-Plus and QFT-GIT in active TB patients was not significant in nearly all studies and ranged from -4.0 to 2.0%. Among high-risk groups, the agreement between OFT-Plus and QFT-GIT was 89.9 to 96.0% (kappa coefficient range, 0.80 to 0.91). The specificity in the low-risk population was slightly lower for QFT-Plus than for OFT-GIT, with the difference ranging from -7.4 to 0%. Further studies are needed to accurately evaluate the sensitivity of QFT-Plus in immunocompromised hosts and children. In addition, further evidence is required to validate a modified interpretation of OFT-Plus for the identification of false-positive results in low-risk health care workers.Keywords
This publication has 34 references indexed in Scilit:
- The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical ModellingPLoS Medicine, 2016
- Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?Journal of Clinical Microbiology, 2016
- Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patientsJournal of Infection, 2014
- Patients with Tuberculosis Disease Have Mycobacterium tuberculosis-Specific CD8 T Cells with a Pro-Apoptotic Phenotype and Impaired Proliferative Capacity, Which Is Not Restored following TreatmentPLOS ONE, 2014
- Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis InfectionClinical Microbiology Reviews, 2014
- Mycobacterium tuberculosis‐specific CD8+ T cells are functionally and phenotypically different between latent infection and active diseaseEuropean Journal of Immunology, 2013
- Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infectionDiagnostic Microbiology and Infectious Disease, 2013
- CD8+T Cells Provide an Immunologic Signature of Tuberculosis in Young ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial LoadPublished by The American Association of Immunologists ,2011
- Polyfunctional CD4+ and CD8+ T Cell Responses to Tuberculosis Antigens in HIV-1–Infected Patients before and after Anti-Retroviral TreatmentPublished by The American Association of Immunologists ,2010